Pancreatic Cancer Research

ResearcherUniversity of Bari Aldo MoroActive in the last 2 years

Maria Raffaella Greco

Matched on ORCID iD 0000-0001-7454-8990; OpenAlex author ID A5044325012. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 10

  1. Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry. Co-author DOI 10.3390/cells15100865↗
  2. Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemc… Co-author DOI 10.3390/cells13090730↗
  3. Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell. Co-author DOI 10.3390/cancers15153868↗
  4. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Co-author DOI 10.3390/cancers14102486↗
  5. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition. First author DOI 10.3390/cancers14153737↗
  6. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as The… Co-author DOI 10.3390/cancers13236135↗
  7. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth. Co-author DOI 10.1038/s42255-020-00315-1↗
  8. Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine. Co-author DOI 10.3390/ijms22010029↗
  9. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome. Co-author DOI 10.1111/febs.14471↗
  10. Assessment of different 3D culture systems to study tumor phenotype and chemosensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2016.3513↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephan J. Reshkin · 10 shared papers, 2016–2026 · strength 1.42
  2. Rosa Angela Cardone · 10 shared papers, 2016–2026 · strength 1.42
  3. Tiago M. A. Carvalho · 6 shared papers, 2020–2024 · strength 0.94
  4. Stefania Cannone · 4 shared papers, 2018–2026 · strength 0.68
  5. Tomas Koltai · 3 shared papers, 2021–2024 · strength 0.51
  6. Katrine Zeeberg · 3 shared papers, 2016–2022 · strength 0.29
  7. Silvia Arpicco · 2 shared papers, 2020–2024 · strength 0.28
  8. Diana Tavares‐Valente · 1 shared paper, 2023 · strength 0.18
  9. Natalia B. Prevarskaya · 1 shared paper, 2024 · strength 0.18
  10. Madelaine Magalì Audero · 1 shared paper, 2024 · strength 0.18
  11. Alessandra Fiorio Pla · 1 shared paper, 2024 · strength 0.18
  12. Stefania Forciniti · 2 shared papers, 2018–2020 · strength 0.17
  13. Elisa Dalla Pozza · 2 shared papers, 2018–2020 · strength 0.17
  14. Marta Palmieri · 2 shared papers, 2018–2020 · strength 0.17
  15. Ilaria Dando · 2 shared papers, 2018–2020 · strength 0.17
  16. Richard Tomasini · 1 shared paper, 2022 · strength 0.15
  17. Olivier Soriani · 1 shared paper, 2022 · strength 0.15
  18. Raffaella Pacchiana · 1 shared paper, 2020 · strength 0.09
  19. Cristian Andres Carmona‐Carmona · 1 shared paper, 2020 · strength 0.09
  20. Giulia Ambrosini · 1 shared paper, 2020 · strength 0.09
  21. Massimo Donadelli · 1 shared paper, 2020 · strength 0.09
  22. Susanna Raho · 1 shared paper, 2020 · strength 0.08
  23. Giuseppe Fiermonte · 1 shared paper, 2020 · strength 0.08
  24. Giulia Biondani · 1 shared paper, 2018 · strength 0.07
  25. Frauke Alves · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.